Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins--similarities and differences.

T Pedersen, A Gaw

    The American Journal of Managed Care
    |June 1, 2001
    PubMed
    Summary
    This summary is machine-generated.

    While statins share similar cholesterol-lowering effects, newer statins have different molecular structures and metabolism. This can lead to varied drug interactions and clinical outcomes, suggesting not all statins are alike.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Enterococcus Cassette Chromosome, a Genomic Variation Enabler in Enterococci.

    mSphere·2018
    Same author

    Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.

    BMC nephrology·2017
    Same author

    30-Day, 90-day and 1-year mortality after emergency colonic surgery.

    European journal of trauma and emergency surgery : official publication of the European Trauma Society·2016
    Same author

    'The principles of a future pharmacology': Johann Christian Reil (1759-1813) and his role in the development of clinical pharmacology.

    European journal of clinical pharmacology·2015
    Same author

    A transparent Pyrex μ-reactor for combined in situ optical characterization and photocatalytic reactivity measurements.

    The Review of scientific instruments·2013
    Same author

    High mass resolution time of flight mass spectrometer for measuring products in heterogeneous catalysis in highly sensitive microreactors.

    The Review of scientific instruments·2012
    Same journal

    Prescription drug prior authorization: costs to pharmacies and physicians.

    The American journal of managed care·2026
    Same journal

    Combined pharmacotherapy and psychotherapy impact on opioid use disorder treatment.

    The American journal of managed care·2026
    Same journal

    The societal costs of food insecurity: implications for managed care strategies.

    The American journal of managed care·2026
    Same journal

    Availability of hospital financial assistance documents in non-English languages.

    The American journal of managed care·2026
    Same journal

    Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

    The American journal of managed care·2026
    Same journal

    Social needs screening and supplemental benefits in Medicare Advantage.

    The American journal of managed care·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Drug Discovery

    Background:

    • The increasing availability of statin medications necessitates a clear understanding of their comparative profiles.
    • Physicians face a growing choice of statins, prompting questions about their similarities and differences.

    Purpose of the Study:

    • To compare the efficacy, safety, and pharmacokinetic profiles of various statin medications.
    • To investigate potential variations in clinical outcomes and drug-drug interactions among different statins.

    Main Methods:

    • Comparative analysis of published data on statin side effects and safety profiles.
    • Dose-response relationship evaluation for lipid reduction across different statins.
    • Examination of molecular structures and metabolic pathways of various statins.

    Related Experiment Videos

    Main Results:

    • Comparisons reveal similar cholesterol-lowering actions, primarily through reducing low-density lipoprotein cholesterol (LDL-C).
    • Distinct molecular structures and metabolic pathways exist among newer statins, potentially influencing their mechanisms of action.
    • Variations in metabolism suggest a risk of significant drug-drug interactions.
    • Differences in lipid reduction levels at varying dosages indicate potential clinical variability.

    Conclusions:

    • Despite similar overall cholesterol-lowering efficacy, differences in molecular structure and metabolism highlight potential variations in drug-drug interactions and clinical effectiveness among statins.
    • The choice of statin may require consideration of individual patient factors and potential interactions beyond basic LDL-C reduction.